company background image
KVUE logo

Kenvue NYSE:KVUE Stock Report

Last Price

US$17.96

Market Cap

US$35.4b

7D

-5.4%

1Y

-29.1%

Updated

12 Jun, 2024

Data

Company Financials +

Kenvue Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kenvue
Historical stock prices
Current Share PriceUS$17.96
52 Week HighUS$26.74
52 Week LowUS$17.82
Beta0
1 Month Change-11.79%
3 Month Change-10.51%
1 Year Change-29.12%
3 Year Changen/a
5 Year Changen/a
Change since IPO-33.23%

Recent News & Updates

Kenvue: A 4% Yield Worth Going Long

Jun 12

Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

May 21
Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

Recent updates

Kenvue: A 4% Yield Worth Going Long

Jun 12

Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

May 21
Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture

Kenvue Q1 Earnings Preview: A Potentially Troubling Trend

May 03

Kenvue: Fairly Valued Spinout

Apr 17

Is Kenvue Inc. (NYSE:KVUE) Trading At A 31% Discount?

Apr 08
Is Kenvue Inc. (NYSE:KVUE) Trading At A 31% Discount?

Kenvue: This Dividend Newcomer Is Worth A Look

Feb 13

Kenvue: What To Expect From Its First Full-Year Report As A Standalone Company

Feb 05

Kenvue: Portfolio Filled Of Market Leaders

Dec 20

Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 42% Above Its Share Price

Dec 07
Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 42% Above Its Share Price

Kenvue: Dude, Where's My Dividend Growth?

Nov 26

Kenvue: Only A Watchlist Stock For Now

Nov 19

There May Be Some Bright Spots In Kenvue's (NYSE:KVUE) Earnings

Nov 10
There May Be Some Bright Spots In Kenvue's (NYSE:KVUE) Earnings

Kenvue: Consumer Health Giant's Journey From IPO To Legal Challenges And Beyond

Oct 19

Kenvue: Interesting Times

Sep 18

Kenvue: Charting A Healthy Future In Consumer Health

Sep 06

Kenvue Split-Off: Still Undecided? 3 (And A Half) Aspects To Consider

Aug 16

Kenvue: A Buffett-Style Investment At A Reasonable Price

Jul 11

Johnson & Johnson Spinoff Kenvue Is Worth Owning - But Maybe Not Yet

Jun 13

Shareholder Returns

KVUEUS Personal ProductsUS Market
7D-5.4%-3.0%1.3%
1Y-29.1%-25.5%21.0%

Return vs Industry: KVUE underperformed the US Personal Products industry which returned -25.5% over the past year.

Return vs Market: KVUE underperformed the US Market which returned 21% over the past year.

Price Volatility

Is KVUE's price volatile compared to industry and market?
KVUE volatility
KVUE Average Weekly Movement3.2%
Personal Products Industry Average Movement9.1%
Market Average Movement5.8%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.8%

Stable Share Price: KVUE has not had significant price volatility in the past 3 months.

Volatility Over Time: KVUE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
202222,000Thibaut Mongonwww.kenvue.com

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Kenvue Inc. Fundamentals Summary

How do Kenvue's earnings and revenue compare to its market cap?
KVUE fundamental statistics
Market capUS$35.37b
Earnings (TTM)US$1.49b
Revenue (TTM)US$15.49b

23.1x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KVUE income statement (TTM)
RevenueUS$15.49b
Cost of RevenueUS$6.73b
Gross ProfitUS$8.76b
Other ExpensesUS$7.27b
EarningsUS$1.49b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.78
Gross Margin56.57%
Net Profit Margin9.63%
Debt/Equity Ratio80.5%

How did KVUE perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

76%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.